Country deep-dive
Single-country regulatory or market reports. How peptides actually move through Danish customs; what the BfArM said about a specific schedule shift; the German press response to a Mounjaro shortage.
Tirzepatide in Netherlands: Mounjaro access
Mounjaro (tirzepatide) has held an EMA marketing authorisation in the Netherlands since 2022. Here is what the licence covers and how Dutch reimbursement works.
What Semax costs in the Netherlands
Semax has no EMA or CBG-MEB authorisation, so there is no official Dutch pharmacy price and no GVS reimbursement. Here is what that means for Dutch readers.
What BPC-157 costs in Denmark
BPC-157 has no marketing authorisation in Denmark: no official price, no pharmacy route, no reimbursement. What the grey-market reality looks like.
BPC-157 Denmark: import rules explained
BPC-157 is unauthorised in Denmark. The 2026 personal import rules explicitly restrict doping substances. What the DKMA says and what customs flags.
What tirzepatide costs in Germany
Cash prices, GKV reimbursement rules, PKV coverage, and the AMNOG process that determines what Mounjaro costs in Germany in 2026.
Tirzepatide Germany: import rules explained
Tirzepatide is EU-authorised as Mounjaro in Germany. What AMG § 73 says about importing it from outside the EU, grey-market risks, and how to get it legally.
PT-141 in Germany: what the law says
Bremelanotide has no EMA or BfArM marketing authorisation. In Germany, the only lawful route is a physician-arranged named-patient import under AMG §73.
Is tesamorelin legal? US, EU, and UK status
Tesamorelin is FDA-approved in the US for HIV-associated lipodystrophy. No EU or UK marketing authorisation exists.
Is tirzepatide legal? EU, UK and US status
Tirzepatide is prescription-only in the US, EU, and UK. Here is what legal access looks like across each jurisdiction.
Is BPC-157 legal? Status by country
BPC-157 is not approved for human use in any country we cover. Here is the regulatory status across the US, EU, and UK as of mid-2026.
Tirzepatide in the UK: how NICE TA924 and TA1026 shape access
Two NICE technology appraisals decide who gets Mounjaro on the NHS and under what criteria. TA924 covers type-2 diabetes; TA1026 covers obesity. They do not overlap.